XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Schedule of Stock Option Activity (Details) - USD ($)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Number of awards, beginning balance 100,235
Weighted avg exercise price per share, beginning balance $ 8.36
Weighted avg grant date fair value per share, beginning Balance $ 7.53
Weighted avg remaining contractual life (in years), beginning Balance 5 years 10 months 17 days
Aggregate intrinsic value, beginning balance $ 620,445
Number of awards, granted
Weighted avg exercise price per share, granted
Weighted avg grant date fair value per share, granted
Weighted avg remaining contractual life (in years), granted
Number of awards, exercised (4,000)
Weighted avg exercise price per share, exercised $ 4.85
Weighted avg grant date fair value per share, exercised $ 4.84
Weighted avg remaining contractual life (in years), exercised 1 month 2 days
Number of awards, expired/forfeited
Weighted avg exercise price per share, expired/forfeited
Weighted avg grant date fair value per share, expired/forfeited
Weighted avg remaining contractual life (in years), expired/forfeited
Number of awards, ending balance 96,235
Weighted avg exercise price per share, ending balance $ 8.67
Weighted avg grant date fair value per share, ending Balance $ 7.64
Weighted avg remaining contractual life (in years), ending Balance 5 years 6 months 21 days
Aggregate intrinsic value, ending balance $ 178,195
Number of awards, exercisable 82,578
Weighted avg exercise price per share, exercisable $ 7.82
Weighted avg grant date fair value per share, exercisable $ 7.22
Weighted avg remaining contractual life (in years), exercisable 5 years 14 days
Aggregate intrinsic value, exercisable $ 174,268
Number of awards, unvested 13,657
Weighted avg exercise price per share, unvested $ 13.61
Weighted avg grant date fair value per share, unvested $ 10.22
Weighted avg remaining contractual life (in years), unvested 8 years 6 months 18 days
Aggregate intrinsic value, unvested $ 3,927